91 related articles for article (PubMed ID: 32638009)
1. Galgo: a bi-objective evolutionary meta-heuristic identifies robust transcriptomic classifiers associated with patient outcome across multiple cancer types.
Guerrero-Gimenez ME; Fernandez-Muñoz JM; Lang BJ; Holton KM; Ciocca DR; Catania CA; Zoppino FCM
Bioinformatics; 2020 Dec; 36(20):5037-5044. PubMed ID: 32638009
[TBL] [Abstract][Full Text] [Related]
2. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.
Gendoo DM; Ratanasirigulchai N; Schröder MS; Paré L; Parker JS; Prat A; Haibe-Kains B
Bioinformatics; 2016 Apr; 32(7):1097-9. PubMed ID: 26607490
[TBL] [Abstract][Full Text] [Related]
3. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
5. MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis.
Kim S; Lin CW; Tseng GC
Bioinformatics; 2016 Jul; 32(13):1966-73. PubMed ID: 27153719
[TBL] [Abstract][Full Text] [Related]
6. Feature specific quantile normalization enables cross-platform classification of molecular subtypes using gene expression data.
Franks JM; Cai G; Whitfield ML
Bioinformatics; 2018 Jun; 34(11):1868-1874. PubMed ID: 29360996
[TBL] [Abstract][Full Text] [Related]
7. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
8. Assessing reproducibility of matrix factorization methods in independent transcriptomes.
Cantini L; Kairov U; de Reyniès A; Barillot E; Radvanyi F; Zinovyev A
Bioinformatics; 2019 Nov; 35(21):4307-4313. PubMed ID: 30938767
[TBL] [Abstract][Full Text] [Related]
9. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
[TBL] [Abstract][Full Text] [Related]
10. Single sample scoring of molecular phenotypes.
Foroutan M; Bhuva DD; Lyu R; Horan K; Cursons J; Davis MJ
BMC Bioinformatics; 2018 Nov; 19(1):404. PubMed ID: 30400809
[TBL] [Abstract][Full Text] [Related]
11. SigMat: a classification scheme for gene signature matching.
Xiao J; Blatti C; Sinha S
Bioinformatics; 2018 Jul; 34(13):i547-i554. PubMed ID: 29950002
[TBL] [Abstract][Full Text] [Related]
12. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
Tan TZ; Ye J; Yee CV; Lim D; Ngoi NYL; Tan DSP; Huang RY
EBioMedicine; 2019 Dec; 50():203-210. PubMed ID: 31761620
[TBL] [Abstract][Full Text] [Related]
14. MetaOmics: analysis pipeline and browser-based software suite for transcriptomic meta-analysis.
Ma T; Huo Z; Kuo A; Zhu L; Fang Z; Zeng X; Lin CW; Liu S; Wang L; Liu P; Rahman T; Chang LC; Kim S; Li J; Park Y; Song C; Oesterreich S; Sibille E; Tseng GC
Bioinformatics; 2019 May; 35(9):1597-1599. PubMed ID: 30304367
[TBL] [Abstract][Full Text] [Related]
15. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed gene sets using the Generalized Berk-Jones statistic.
Gaynor SM; Sun R; Lin X; Quackenbush J
Bioinformatics; 2019 Nov; 35(22):4568-4576. PubMed ID: 31062858
[TBL] [Abstract][Full Text] [Related]
17. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
18. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
20. GSMA: an approach to identify robust global and test Gene Signatures using Meta-Analysis.
Shafi A; Nguyen T; Peyvandipour A; Draghici S
Bioinformatics; 2020 Jan; 36(2):487-495. PubMed ID: 31329248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
